Q. Patient presents with several weeks of progressive neurobehavioral symptoms, delirium, and partial seizures. MRI demonstrates medial temporal lobe hyperintensity. Of the following, which autoantibody or autoantibodies should you potentially anticipate being identified in this disorder?